Is a complete AIM/CREO research report available?

No complete published report is available for aim/CREO (AIM/CREO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

aim/CREO stock profile: metrics, valuation and analysis

Market cap	56.1M
Revenue (ttm)	6M
Net income (ttm)	5.3M
EPS (ttm)	GBX 0.01
Shares out	449.1M
P/E (trailing)	10.6x
Volume	313,468
Beta	0.91

All AIM/CREO indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

GBP

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	104
Employees Change	-25%
Employees Change Percent	-19.38
Enterprise value	GBX 47.8M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Medical Devices
Industry PE	18.89
Industry PE Fwd	12.75
Isin	GB00BZ1BLL44
Last refreshed	2026-09-11
Market cap	GBX 56.1M
Price	GBX 12.33
Price currency	GBX
Rev Per Employee	57,692.31x
Sector	Healthcare
Sector PE	21.2
Sector PE Fwd	13.53
Sic	3845
Symbol	aim/CREO
Website	https://www.creomedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.44%
EV Earnings	9.03x
EV/Sales	7.97x
FCF yield	-34.02%
P/B ratio	1.12x
P/E ratio	10.59x
P/S ratio	9.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	40%
Gross Profit	GBX 2.4M
Gross Profit Growth3 Y	-41.44%
Gross Profit Growth5 Y	347.72%
Net Income	GBX 5.3M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-291.67%
Profit Margin	88.33%
Profit Per Employee	GBX 50,962
Profitable Years	1
ROA	-19.44
Roa5y	-21.36
ROCE	-37.26
ROE	-37.88
Roe5y	-43.15
ROIC	-44.73

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-2.38%
Cagr3y	-27.61%
Cagr5y	-41.89%
EPS Growth Quarters	6
EPS Growth Years	1
Revenue Growth	50x
Revenue Growth Years	1x
Revenue Growth3 Y	-38.55x
Revenue Growth5 Y	278.01x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.1
Assets	GBX 59.1M
Cash	GBX 12.4M
Current Assets	GBX 23.5M
Current Liabilities	GBX 7.3M
Debt	GBX 4.1M
Debt Equity	GBX 0.08
Debt FCF	GBX -0.21
Equity	GBX 50M
Interest Coverage	-64.33
Liabilities	GBX 9.1M
Long Term Assets	GBX 35.6M
Long Term Liabilities	GBX 1.8M
Net Cash	GBX 8.3M
Net Cash By Market Cap	GBX 14.78
Net Cash Growth	93.02%
Net Debt Equity	GBX -0.17
Tangible Book Value	GBX 49.8M
Tangible Book Value Per Share	GBX 0.12
WACC	9.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.22
Inventory Turnover	1.38
Net Working Capital	GBX 6.1M
Quick ratio	2.59
Working Capital	GBX 16.2M
Working Capital Turnover	GBX 0.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-2.38%
200-day SMA	12.9
3Y total return	-62.08%
50-day SMA	13.34
50-day SMA vs 200-day SMA	50over200
5Y total return	-93.37%
All Time High	250
All Time High Change	-95.07%
All Time High Date	2018-10-02
All Time Low	9.22
All Time Low Change	33.68%
All Time Low Date	2025-04-23
ATR	0.44
Beta	0.91
Beta1y	1.32
Beta2y	1.01
Ch YTD	24.5
High	12.75
High52	18.5
High52 Date	2026-02-05
High52ch	-33.38%
Low	12.3
Low52	9.52
Low52 Date	2025-12-04
Low52ch	29.47%
Ma50ch	-7.57%
Price vs 200-day SMA	-4.46%
RSI	36.82
RSI Monthly	38.69
RSI Weekly	45.48
Sharpe ratio	0.17x
Sharpe Ratio3y	-0.42x
Sharpe Ratio5y	-0.75x
Sortino ratio	0.48
Sortino Ratio3y	-0.57
Sortino Ratio5y	-1.21
Total Return	-14.38%
Tr YTD	24.5
Tr1m	-3.33%
Tr1w	-4.27%
Tr3m	-9.37%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	410,572,981%
Net Borrowing	-600,000
Shares Insiders	3.21%
Shares Institutions	78.66%
Shares Out	449,139,983
Shares Yo Y	14.38%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -20.5M
Adjusted OCF	-20,500,000
Average Volume	645,221.85x
Bv Per Share	0.12
CAPEX	GBX -300,000
Ch1m	-3.33
Ch1w	-4.27
Ch1y	-2.41
Ch3m	-9.37
Ch3y	-62.08
Ch5y	-93.37
Ch6m	-10.36
Change	-2.38%
Change From Open	-3.26
Close	12.63
Days Gap	0.87
Depreciation Amortization	700,000
Dollar Volume	3,863,524.4
Earnings Date	2026-09-17
EBIT	GBX -19.3M
EBITDA	GBX -18.6M
EPS	GBX 0.01
F Score	2
FCF	GBX -19.1M
FCF EV Yield	-39.92x
FCF Per Share	GBX -0.04
Financing CF	-700,000
Fiscal Year End	December
Founded	2,003
Graham Number	18.721
Graham Upside	51.89
Investing CF	19,900,000
Is Primary Listing	1
Last Earnings Date	2025-12-23
Last Report Date	2025-12-31
Ma150	13.44
Ma150ch	-8.32%
Ma20	12.8
Ma20ch	-3.68%
Net CF	100,000
Next Earnings Date	2026-09-17
Open	12.74
Position In Range	5.58
Ppne	3,400,000
Price Date	2026-09-10
Ptbv Ratio	1.13
Relative Volume	0.49x
Revenue	6,000,000x
SBC By Revenue	23.33x
Share Based Comp	1,400,000
Tr6m	-10.36%
Volume	313,468
Z Score	-1.15

AIM/CREO (AIM/CREO)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/CREO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/CREO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on AIM/CREO

Frequently asked questions